期刊文献+

胱抑素C与多项血清学指标对急性心力衰竭患者预后价值的相关性研究 被引量:12

胱抑素C与多项血清学指标对急性心力衰竭患者预后价值的相关性研究
下载PDF
导出
摘要 目的探讨血清胱抑素C(Cys-C)及几多项血清指标(NT-proBNP、肌钙蛋白T、超敏C反应蛋白、肌酐等)在急性心力衰竭(AHF)患者中的表达水平和评价其预后价值及相关性。方法入选2007~2009年因急性心力衰竭患者136例,入院即测定Cys-C、NT-proBNP、c-TNT、hs-CRP、SCr等多项血清学指标观察其表达水平。平均随访1年,记录各组心脏全因死亡率和因心衰再次住院率,评价各项指标对急性心衰预后预测价值及相关性。结果 136名患者中61名发生不良临床事件,随着Cys-C浓度升高发生率增加(分别为29.3%、40.8%、63.1%,P<0.05);且Cys-C、NT-proBNP、c-TNT同时升高的数量越多,发生率也随之增加(分别为38.1%,44.2%,67.7%,P<0.05)。结论 Cys-C、NT-proBNP、c-TNT具有独立预测价值,而联合三者对急性心力衰竭进行危险评估可提高其预测价值,有助于识别高危患者。 Objective To evaluate the prognostic value of cystatin C and some of serum markers(NT-pro-BNP,c-TnT,Hs-CRP,creatinine,etc.) in the risk stratification of an unselected cohort of patients with acute heart failure.Methods 136 hospitalized patients with established diagnoses of acute heart failure were prospectively studied.Blood samples were collected on hospital arrival to determine Cys-C、NT-proBNP、c-TNT、hs-CRP、SCr ete.Clinical follow-up(1 year) was obtained,and the occurrence of mortality and/or heart failure readmission was regist.Results 61 patients(44.9%) presented with adverse events,,and with the Cys-C concentration increased,the incidence increased(respectively 29.3%,40.8%,63.1% P 0.05);At the same time the more increasing number of Cys-C,NT-proBNP,c-TNT,the more increasing incidence(respectively 38.1%,44.2%,67.7% P 0.05).Conclusion Cys-C,NT-pro-BNP,c-TNT has independent predictive value,and the three joint risk assessment of acute heart failure can improve their predictive value,help to identify high-risk patients.
出处 《当代医学》 2011年第36期21-22,共2页 Contemporary Medicine
关键词 胱抑素C 急性心力衰竭 血清标志物 Cystatin C Acute heart failure serum markers
  • 相关文献

参考文献8

  • 1Pascual-Figal DA,Manzano-Fernandez S,Pastor F,et al.Troponin T monitoring in outpatients with nonischemic heart failure[J].Rev Esp Cardiol 2008,61:678-686.
  • 2Perna ER,Macin SM,Cimbaro Canella JP,et al.Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure[J].Int J Cardio l2005,99:253-261.
  • 3van Kimmenade RR,Pinto YM,Bayes-Genis A,et al.Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure[J].Am J Cardiol2006,98:386-390.
  • 4Taniguchi R,Sato Y,Yamada T.Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure[J].Circ J 2004,68:1160-1164.
  • 5任爱英,王凡.血清胱抑素C的临床应用及研究[J].检验医学与临床,2008,5(1):32-34. 被引量:45
  • 6Shlipak MG,Katz R,Fried LF,et al.Cystatin C and mortality in elderly persons with heart failure[J].J Am Coll Cardiol,2005,45(2):268-271.
  • 7Moran A,Kata R,Smith NL,et al.Cystatin C concentration as a predictor of systolic and diastolic heart failure[J].J Card Fail,2008,14(1):19-26.
  • 8Arimoto T,Takeishi Y,Niizeki T,et al.Cystatin C,a novel measure of renal function,is an in dependent predictor of cardiac events inpatients with heart failure[J].J Card Fail,2005,11:595-601.

二级参考文献6

  • 1[1]Anderson JK,Schmidt C,Nordin G,et al.determined by a rapid,automated particle-enhanced turbidi metric method,is a batter marker than serum creatinine for glomerular filtration rate[J].Clin Chem,1994,40(10):1921-1926.
  • 2[2]Finney H,Newman DJ,Gruber W.Initial evaluation of cystatin c measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems(BNA,BN11)[J].Clin Chem,1997,43(6):1016-1020.
  • 3[3]Randers E,Erlanden EJ.Serum Cystatin C as an endogenous marker of the renal function ; a review[J].Clin Chem Labmed,1999,37(4):389-395.
  • 4[5]Pergande M,Jung K.Sandwich enzy me immunoassay of Cystatin C in serum with commercially available antibodies[J].Chin Chem,1993,39(9):1885-1990.
  • 5[6]Randers E,Erlandsen EJ,Pederson QL.Serum Cystatin C as an endogenous parameter of renal function in patients with normal to moderately impaired kidney function[J].Chin Nephrol,2000,54(3):203-209.
  • 6孙诠,程改花,冯建芳,汪淑荣,师树古,陈明哲.巯基蛋白酶抑制肽促进乳鼠心肌细胞贴壁和生长[J].北京医科大学学报,1993,25(4):281-283. 被引量:13

共引文献44

同被引文献80

  • 1薛红新,赵思义,程训民,李淑玲,周鸿雁,王敬雨.血清肌钙蛋白I与老年心力衰竭患者心肌损伤和心脏事件关系的临床研究[J].中国现代医学杂志,2005,15(2):275-277. 被引量:6
  • 2饶大勇,许贤德.慢性心力衰竭患者血清总胆红素水平对预后判断的临床观察[J].中国心血管杂志,2006,11(5):378-379. 被引量:7
  • 3王清平.肌钙蛋白I定性检测在急诊科诊断AMI的应用价值[J].医学临床研究,2006,23(12):1880-1881. 被引量:3
  • 4中华医学会心血管病学分会.性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(2) 195-1 96.
  • 5Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients withheart failure: a population—based study[J],Eur Heart J,2002,23(4).877—885.
  • 6Yancy CW, Jessup M, Bozkurt B, et al . 2013 ACCF/AHA guideline for the management of heart failure: executive sum- mary : a report of the American College of Cardiology Founda- tion/American Heart Association Task Force on practice guidelines[J]. Circulation ,2013, 128(16).. 1810-1852.
  • 7Bourassa MG, Gurne O, Bangdiwala SI, et al . Natural histo- ry and patterns of current practice in heart failure. The Stud- ies of Left Ventrieular Dysfunction (SOLVD) Investigators [J]. J Am Coll Cardiol ,1993, 22(4 Suppl A).. 14A-19A.
  • 8Miller WL, Grill DE, Jaffe AS. Comparison of novel pro- BNP(1-108) and standard BNP assays in heart :ailure patients [J]. Clin ChimActa ,2012, 413(9-10): 920-926.
  • 9de Antonio M, Lupon J, Galan A, et al . Combined use ofhigh-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance o- ver established mortality risk factors in chronic heart failure [J]. Am Heart J ,2012, 163(5): 821-828.
  • 10孙丽杰,张福春,李丹,等.总胆红素水平对住院慢性心力衰竭患者远期预后影响[J].中国内科杂志,2012,51(9):677-679.

引证文献12

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部